Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 13c, Raises FY Revenue Guidance
Go back to Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 13c, Raises FY Revenue Guidance| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 230.56 -5.61 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.17 | 52 Week High | $160.00 | |||
| Open | $235.44 | 52 Week Low | $95.80 | |||
| Day High | $236.44 | P/E | 42.86 | |||
| Day Low | $230.05 | EPS | $5.38 | |||
| Volume | 635,734 | |||||
